23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

KD Ventures appoints Johan Dighed as new CEO

The life science investment company KD Ventures has appointed Johan Dighed as its new CEO, taking office on 16 November. He succeeds Viktor Drvota, who is leaving the position after more than nine years.
Advertisement

Dighed has been the company’s general counsel since 2020 and deputy CEO since 2021. He previously served as general counsel of SEB’s German subsidiary SEB AG.

KD Ventures will now focus on developing value in its existing portfolio and carrying out divestments. Drvota will assist during a transition period and temporarily continue his involvement in certain portfolio companies.

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
People & Careers See topic
Advertisement Advertisement
BREAKING
{{ article.headline }}
0.056|